These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
90 related items for PubMed ID: 89850
1. Mechanism of action studies of lidamidine hydrochloride (WHR-1142A), a novel antidiarrheal agent. Mir GN, Sperow JW, Krebs JB, Eash JR, Rowles GS, Yelnosky J. Arzneimittelforschung; 1978; 28(8a):1454-61. PubMed ID: 89850 [Abstract] [Full Text] [Related]
2. In vivo antimotility and antidiarrheal activity of lidamidine hydrochloride (WHR-1142A), a novel antidiarrheal agent. Comparison with diphenoxylate and loperamide. Mir GN, Alioto RL, Sperow JW, Eash JR, Krebs JB, Yelnosky J. Arzneimittelforschung; 1978; 28(8a):1448-54. PubMed ID: 582536 [Abstract] [Full Text] [Related]
3. Effects of lidamidine hydrochloride (WHR-1142A), a novel antidiarrheal agent on the cardiovascular and central nervous systems. Riley RL, Mir GN, Rowles GS, Sperow JW, Alioto RL, Yelnosky J. Arzneimittelforschung; 1978; 28(8a):1461-6. PubMed ID: 582537 [Abstract] [Full Text] [Related]
4. Pharmacological properties of lidamidine hydrochloride (WHR-1142A), a novel antidiarrheal agent. Mir GN, Sperow JW, Riley RL, Alioto RL, Nuss GW, Chou BJ, Yelnosky J. Arzneimittelforschung; 1978; 28(8a):1466-70. PubMed ID: 582538 [Abstract] [Full Text] [Related]
7. Loperamide (R 18 553), a novel type of antidiarrheal agent. Part 3: in vitro studies on the peristaltic reflex and other experiments on isolated tissues. Van Nueten JM, Janssen PA, Fontaine J. Arzneimittelforschung; 1974 Oct; 24(10):1641-5. PubMed ID: 4479777 [No Abstract] [Full Text] [Related]
8. Pharmacokinetics and disposition of lidamidine hydrochloride (WHR-1142A), a novel antidiarrheal agent, in rat and monkey. DeLong AF, Martin GP, Polk A, Carter V, Herczeg T. Arzneimittelforschung; 1978 Oct; 28(8a):1477-80. PubMed ID: 113016 [Abstract] [Full Text] [Related]
11. Role of alpha-2 adrenergic receptors in the control of diarrhea and intestinal motility. Doherty NS, Hancock AA. J Pharmacol Exp Ther; 1983 May; 225(2):269-74. PubMed ID: 6132991 [Abstract] [Full Text] [Related]
12. WHR 1049, a potent metabolite of lidamidine, has antidiarrheal and antimotility effects on the small intestine in rats. Eaker EY, Bixler GB, Mathias JR. J Pharmacol Exp Ther; 1988 Aug; 246(2):786-9. PubMed ID: 3404458 [Abstract] [Full Text] [Related]
13. Antidiarrheal and central nervous system activities of SC-27166 (2-[3 - 5 - methyl - 1, 3, 4 - oxadiazol - 2 - yl) - 3, 3 - diphenylpropyl] - 2 - azabicyclo [2.2.2]octane), a new antidiarrheal agent, resulting from binding to opiate receptor sites of brain and myenteric plexus. Mackerer CR, Brougham LR, East PF, Bloss JL, Dajani EZ, Clay GA. J Pharmacol Exp Ther; 1977 Dec; 203(3):527-38. PubMed ID: 200732 [Abstract] [Full Text] [Related]
14. Selective potentiation by ouabain of naloxone-induced withdrawal contractions of isolated guinea-pig ileum following acute exposure to morphine. Mundey MK, Mason R, Wilson VG. Br J Pharmacol; 1998 Jul; 124(5):911-6. PubMed ID: 9692776 [Abstract] [Full Text] [Related]
15. Interactions between histaminergic and cholinergic pathways of gastric motility regulation. Milenov K, Todorov S, Vassileva M, Zamfirova R, Shahbazian A. Methods Find Exp Clin Pharmacol; 1996 Jul; 18(1):33-9. PubMed ID: 8721254 [Abstract] [Full Text] [Related]
16. Some aspects in the pharmacology of diclonium bromide (2-(3,2-dichloroanilino)quinolizinium bromide). Part I: Antispasmodic action. Goldenberg MM. Arzneimittelforschung; 1976 Jul; 26(3):341-6. PubMed ID: 9098 [Abstract] [Full Text] [Related]
17. General pharmacological studies on N-(2,6-dimethylphenyl)-8-pyrrolizidineacetamide hydrochloride hemihydrate. 2nd communication: effect on the peripheral nervous system and peripheral organs. Hirotsu I, Kihara T, Hattori Y, Hatta M, Hirose N, Ishihara T, Satoh F. Arzneimittelforschung; 1988 Oct; 38(10):1410-7. PubMed ID: 3196381 [Abstract] [Full Text] [Related]
18. The influence of serotonin and histamine on contractility of the smooth muscle of the digestive tract in experimental animals. Kedzierska L. Arch Immunol Ther Exp (Warsz); 1970 Oct; 18(2):239-57. PubMed ID: 5420945 [No Abstract] [Full Text] [Related]
19. General pharmacological profile of the new cognition-enhancing agent nefiracetam. Kitano Y, Makino M, Usui C, Takasuna K, Kasai Y, Hirohashi M, Tamura K, Takayama S, Kojima H, Iizuka H. Arzneimittelforschung; 1994 Feb; 44(2A):199-210. PubMed ID: 8018090 [Abstract] [Full Text] [Related]